Back to Search
Start Over
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries
- Source :
- European respiratory journal, 46(6), 1563-1576. European Respiratory Society, The European Respiratory Journal, Getahun, H, Matteelli, A, Abubakar, I, Aziz, M A, Baddeley, A, Barreira, D, Den Boon, S, Borroto Gutierrez, S M, Bruchfeld, J, Burhan, E, Cavalcante, S, Cedillos, R, Chaisson, R, Chee, C B-E, Chesire, L, Corbett, E, Dara, M, Denholm, J, de Vries, G, Falzon, D, Ford, N, Gale-Rowe, M, Gilpin, C, Girardi, E, Go, U-Y, Govindasamy, D, Grant, A D, Grzemska, M, Harris, R, Horsburgh, C R, Ismayilov, A, Jaramillo, E, Kik, S, Kranzer, K, Lienhardt, C, LoBue, P, Lönnroth, K, Marks, G, Menzies, D, Migliori, G B, Mosca, D, Mukadi, Y D, Mwinga, A, Nelson, L, Nishikiori, N, Oordt-Speets, A, Rangaka, M X, Reis, A, Rotz, L, Sandgren, A, Sañé Schepisi, M, Schünemann, H J, Sharma, S K, Sotgiu, G, Stagg, H R, Sterling, T R, Tayeb, T, Uplekar, M, van der Werf, M J, Vandevelde, W, van Kessel, F, van't Hoog, A, Varma, J K, Vezhnina, N, Voniatis, C, Vonk Noordegraaf-Schouten, M, Weil, D, Weyer, K, Wilkinson, R J, Yoshiyama, T, Zellweger, J P & Raviglione, M 2015, ' Management of latent Mycobacterium tuberculosis infection : WHO guidelines for low tuberculosis burden countries ', European Respiratory Journal, vol. 46, no. 6, pp. 1563-1576 . https://doi.org/10.1183/13993003.01245-2015
- Publication Year :
- 2021
- Publisher :
- The Francis Crick Institute, 2021.
-
Abstract
- Latent tuberculosis infection (LTBI) is characterised by the presence of immune responses to previously acquired Mycobacterium tuberculosis infection without clinical evidence of active tuberculosis (TB). Here we report evidence-based guidelines from the World Health Organization for a public health approach to the management of LTBI in high risk individuals in countries with high or middle upper income and TB incidence of<br />Guidelines on LTBI for low TB incidence countries – essential element of the @WHO #EndTB strategy and TB elimination http://ow.ly/RW8xn
- Subjects :
- Gerontology
Thoracic
Antitubercular Agents
Antirheumatic Agents/therapeutic use
HIV Infections
Comorbidity
Kidney Failure
Drug Users
Substance-Related Disorders/epidemiology
Mass Screening
Medicine
Chronic
Human Biology & Physiology
Evidence-Based Medicine
Latent tuberculosis
biology
Coinfection
Medicine (all)
Disease Management
Homeless Persons
Antirheumatic Agents
Emigrants and Immigrants
Health Personnel
Humans
Interferon-gamma Release Tests
Isoniazid
Kidney Failure, Chronic
Latent Tuberculosis
Practice Guidelines as Topic
Prisoners
Public Health
Radiography, Thoracic
Renal Dialysis
Rifampin
Risk Assessment
Silicosis
Substance-Related Disorders
Transplant Recipients
Tuberculin Test
Tumor Necrosis Factor-alpha
World Health Organization
Pulmonary and Respiratory Medicine
HIV Infections/epidemiology
Ill-Housed Persons
Latent Tuberculosis/diagnosis
Perspectives
medicine.drug
Model organisms
medicine.medical_specialty
Tuberculosis
Isoniazid/therapeutic use
Antitubercular Agents/therapeutic use
Immunology
Tuberculin
Infectious Disease
Mycobacterium tuberculosis
Silicosis/epidemiology
Internal medicine
Coinfection/epidemiology
Kidney Failure, Chronic/epidemiology
Mass screening
Tumor Necrosis Factor-alpha/antagonists & inhibitors
business.industry
FOS: Clinical medicine
Rifampin/analogs & derivatives
medicine.disease
biology.organism_classification
bacterial infections and mycoses
Rifapentine
Radiography
Transplantation
business
Rifampicin
Subjects
Details
- ISSN :
- 09031936
- Database :
- OpenAIRE
- Journal :
- European respiratory journal, 46(6), 1563-1576. European Respiratory Society, The European Respiratory Journal, Getahun, H, Matteelli, A, Abubakar, I, Aziz, M A, Baddeley, A, Barreira, D, Den Boon, S, Borroto Gutierrez, S M, Bruchfeld, J, Burhan, E, Cavalcante, S, Cedillos, R, Chaisson, R, Chee, C B-E, Chesire, L, Corbett, E, Dara, M, Denholm, J, de Vries, G, Falzon, D, Ford, N, Gale-Rowe, M, Gilpin, C, Girardi, E, Go, U-Y, Govindasamy, D, Grant, A D, Grzemska, M, Harris, R, Horsburgh, C R, Ismayilov, A, Jaramillo, E, Kik, S, Kranzer, K, Lienhardt, C, LoBue, P, Lönnroth, K, Marks, G, Menzies, D, Migliori, G B, Mosca, D, Mukadi, Y D, Mwinga, A, Nelson, L, Nishikiori, N, Oordt-Speets, A, Rangaka, M X, Reis, A, Rotz, L, Sandgren, A, Sañé Schepisi, M, Schünemann, H J, Sharma, S K, Sotgiu, G, Stagg, H R, Sterling, T R, Tayeb, T, Uplekar, M, van der Werf, M J, Vandevelde, W, van Kessel, F, van't Hoog, A, Varma, J K, Vezhnina, N, Voniatis, C, Vonk Noordegraaf-Schouten, M, Weil, D, Weyer, K, Wilkinson, R J, Yoshiyama, T, Zellweger, J P & Raviglione, M 2015, ' Management of latent Mycobacterium tuberculosis infection : WHO guidelines for low tuberculosis burden countries ', European Respiratory Journal, vol. 46, no. 6, pp. 1563-1576 . https://doi.org/10.1183/13993003.01245-2015
- Accession number :
- edsair.doi.dedup.....187409e0f497106e513edd06d3443058
- Full Text :
- https://doi.org/10.25418/crick.15277998